Skip to main content
Novartis AG logo

Novartis AG — Investor Relations & Filings

Ticker · NOVN ISIN · CH0038459415 LEI · 5493007HIVTX6SY6XD66 SW Manufacturing
Open in API
Filings indexed 1,070 across all filing types
Latest filing 2016-05-17 Board/Management Inform…
Country CH Switzerland
Listing SW NOVN

About Novartis AG

https://www.novartis.com/

Novartis AG is a global medicines company focused on the research, development, manufacturing, and marketing of innovative healthcare products. The company's mission is to reimagine medicine to improve and extend people's lives. By leveraging advanced science and technology, Novartis develops a portfolio of treatments across various therapeutic areas to address the evolving needs of patients and societies. The firm is committed to delivering high-value medicines that tackle some of the most challenging healthcare issues worldwide.

Recent filings

Filing Released Lang Actions
FORM 6-K
Board/Management Information Classification · 95% confidence The document is a Form 6-K filed by Novartis AG, which is a report of a foreign private issuer pursuant to SEC rules. The content primarily announces organizational changes in the company's Pharmaceuticals Division, including appointments to the Executive Committee and leadership changes. There are no financial statements, detailed financial analysis, or earnings data presented. The document is a regulatory announcement about management changes and business unit restructuring rather than a full annual or interim report, earnings release, or detailed management discussion. It is not a certification or attestation document. Given the nature of the content and the form type (6-K), this fits best under the category of Board/Management Information (MANG), which covers announcements of changes in senior management or board members. The document length (over 10,000 characters) supports it being a substantive announcement rather than a brief notice. Therefore, the classification is MANG with high confidence.
2016-05-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-05-12 English
FORM 3 SUBMISSION
Director's Dealing
2016-05-06 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Novartis AG, which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. It references exhibits including a Financial Report for Q1 2016 and an Interim Financial Report. The document length is only 1483 characters, which is quite short and does not contain actual financial statements or substantive financial data itself. Instead, it appears to be a cover or transmittal report for the attached or referenced interim financial reports. According to the MENU VS MEAL RULE, such a short document that references reports but does not contain the reports themselves should be classified as a Regulatory Filing (RNS) rather than an Interim Report (IR).
2016-04-21 English
FORM 4
Director's Dealing
2016-04-12 English
FORM 3/A
Director's Dealing
2016-04-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.